Members-only webinar

Unlock the full webinar

Go beyond the script with clinical and regulatory insight from leaders in longevity medicine. Stay ahead of the curve. One quick form, under 30 seconds, unlocks every Southend webinar.

Get instant access

30 seconds or less.

One form unlocks every Southend webinar on this device.

Navigating Regulatory Change in Practice | Presented by Darren Frank- Attorney and CEO of Infusive.

Haley Collavo

Content Editor

The regulatory landscape is shifting — and staying ahead of it requires more than awareness.

It requires a plan. In this webinar, Southend Pharmacy is joined by Darren C. Frank, Attorney and CEO of Infusive, for a practical, provider-focused conversation on what today’s evolving regulatory environment means for your practice and how to navigate it with confidence.

Disclaimer: Compounded medications are not reviewed or verified by the FDA for safety, effectiveness, or quality and are not FDA-approved. Instead, compounded drugs may be prepared, or compounded, for patients who cannot be treated with an FDA-approved medication. In situations like this, compounding can serve important patient needs. A licensed healthcare provider will evaluate if treatment involving a compounded medication is necessary or appropriate for you. 503A pharmacies are required to comply with FDA rules, regulations, and guidance, among other applicable laws, rules, regulations, and guidance.

Key takeaways
  • Key developments shaping the current regulatory landscape
  • Considerations for patient access and continuity of care
  • Marketing and communication best practices in a changing environment
  • Strategies for supporting practice stability, operational compliance, and practice growth

Compliance. Expertise. Quality. Speed.
Four pillars defining a higher standard for the compounding industry.

Scroll to Top